PGR and breast cancer: Most of the proteomic studies reported on cellular models are exclusively conducted on Triple-negative (TN) BC (TNBC) tumor subtypes, any BC characterized by the lack of expression of estrogen and progesterone receptor, and of human epidermal growth factor receptor 2.